In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 1, 2011, Pages 197-202

  Siswantoro, H ^a   Russel, B ^b,c   Ratcliff, A ^b   Prasetyorini, B ^a   Chalfein, F ^d   Marfurt, J ^b   Kenangalem, E ^d,e   Wuwung, M ^g   Piera, K A ^b   Ebsworth, E P ^f,g   Anstey, N M ^b   Tjitra, E ^a   Price, R N ^b,h  

^a NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c AGENCY FOR SCIENCE   (Singapore)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e District Health Office   (Indonesia)

^f Public Health and Malaria Control Department Papua   (Indonesia)

^g International SOS ^*  (Indonesia)

^h JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DOXYCYCLINE; PRIMAQUINE; QUININE;

ADOLESCENT; ANEMIA; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CHILD; DRUG EFFICACY; FEMALE; GAMETOCYTE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INDONESIA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PLASMODIUM MALARIAE; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE; PLASMODIUM OVALE MALARIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHIZONT; SCHOOL CHILD; TROPHOZOITE;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; FEMALE; HUMANS; INDONESIA; MALARIA; MALE; MIDDLE AGED; PLASMODIUM MALARIAE; PLASMODIUM OVALE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 78650647223     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01122-10     Document Type: Article

References (31)

1. Baird, J. K. 2009. Resistance to therapies for infection by Plasmodium vivax. Clin. Microbiol. Rev. 22:508-534.
2. Barnadas, C., A. Ratsimbasoa, H. Ranaivosoa, D. Ralaizandry, D. Raveloariseheno, V. Rabekotonorina, S. Picot, and D. Menard. 2007. Short report: prevalence and chloroquine sensitivity of Plasmodium malariae in Madagascar. Am. J. Trop. Med. Hyg. 77:1039-1042.
3. Basco, L. K., and J. Le Bras. 1994. Short-term in vitro culture of Plasmodium vivax and P. ovale for drug-susceptibility testing. Parasitol. Res. 80:262-264.
4. Cavasini, M. T., W. L. Ribeiro, F. Kawamoto, and M. U. Ferreira. 2000. How prevalent is Plasmodium malariae in Rondonia, western Brazilian Amazon? Rev. Soc. Bras. Med. Trop. 33:489-492.
5. Collins, W. E., and G. M. Jeffery. 2002. Extended clearance time after treatment of infections with Plasmodium malariae may not be indicative of resistance to chloroquine. Am. J. Trop. Med. Hyg. 67:406-410.
6. Collins, W. E., and G. M. Jeffery. 2007. Plasmodium malariae: parasite and disease. Clin. Microbiol. Rev. 20:579-592.
7. Hasugian, A. R., E. Tjitra, A. Ratcliff, H. Siswantoro, E. Kenangalem, R. M. Wuwung, H. L. Purba, K. A. Piera, F. Chalfien, J. Marfurt, P. M. Penttinen, B. Russell, N. M. Anstey, and R. N. Price. 2009. In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquineresistant Plasmodium vivax. Antimicrob. Agents Chemother. 53:1094-1099.
8. Karyana, M., L. Burdarm, S. Yeung, E. Kenangalem, N. Wariker, R. Maristela, K. G. Umana, R. Vemuri, M. J. Okoseray, P. M. Penttinen, P. Ebsworth, P. Sugiarto, N. M. Anstey, E. Tjitra, and R. N. Price. 2008. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar. J. 7:148.
9. Lee, V. H., S. Atmosoedjono, S. Aep, and C. D. Swaine. 1980. Vector studies and epidemiology of malaria in Irian Jaya, Indonesia. Southeast Asian J. Trop. Med. Public Health 11:341-347.
10. Maguire, J. D., I. W. Sumawinata, S. Masbar, B. Laksana, P. Prodjodipuro, I. Susanti, P. Sismadi, N. Mahmud, M. J. Bangs, and J. K. Baird. 2002. Chloroquine-resistant Plasmodium malariae in south Sumatra, Indonesia. Lancet 360:58-60.
11. Mayxay, M., S. Pukrittayakamee, P. N. Newton, and N. J. White. 2004. Mixed-species malaria infections in humans. Trends Parasitol. 20:233-240.
12. Mueller, I., P. A. Zimmerman, and J. C. Reeder. 2007. Plasmodium malariae and Plasmodium ovale-the "bashful" malaria parasites. Trends Parasitol. 23:278-283.
13. Padley, D., A. H. Moody, P. L. Chiodini, and J. Saldanha. 2003. Use of a rapid, single-round, multiplex PCR to detect malarial parasites and identify the species present. Ann. Trop. Med. Parasitol. 97:131-137.
14. Pribadi, W., I. Sutanto, S. Atmosoedjono, R. Rasidi, L. K. Surya, and L. Susanto. 1998. Malaria situation in several villages around Timika, south central Irian Jaya, Indonesia. Southeast Asian J. Trop. Med. Public Health 29:228-235.
15. Pukrittayakamee, S., A. Chantra, J. A. Simpson, S. Vanijanonta, R. Clemens, S. Looareesuwan, and N. J. White. 2000. Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob. Agents Chemother. 44:1680-1685.
16. Ratcliff, A., H. Siswantoro, E. Kenangalem, M. Wuwung, A. Brockman, M. D. Edstein, F. Laihad, E. P. Ebsworth, N. M. Anstey, E. Tjitra, and R. N. Price. 2007. Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia. Trans. R. S. Trop. Med. Hyg. 101:351-359.
17. Ringwald, P., J. Bickii, A. Same-Ekobo, and L. K. Basco. 1997. Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections. Antimicrob. Agents Chemother. 41:2317-2319.
18. Russell, B., F. Chalfein, B. Prasetyorini, E. Kenangalem, K. Piera, R. Suwanarusk, A. Brockman, P. Prayoga, P. Sugiarto, Q. Cheng, E. Tjitra, N. M. Anstey, and R. N. Price. 2008. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob. Agents Chemother. 52:1040-1045.
19. Sharrock, W. W., R. Suwanarusk, U. Lek-Uthai, M. D. Edstein, V. Kosaisavee, T. Travers, A. Jaidee, K. Sriprawat, R. N. Price, F. Nosten, and B. Russell. 2008. Plasmodium vivax trophozoites insensitive to chloroquine. Malar. J. 7:94.
20. Siala, E., M. Khalfaoui, A. Bouratbine, S. Hamdi, K. Hili, and K. Aoun. 2005. Relapse of Plasmodium malariae malaria 20 years after living in an endemic area. Presse Med. 34:371-372.
21. Siswantoro, H., A. Ratcliff, E. Kenangalem, M. Wuwung, R. Maristela, R. Rumaseuw, F. Laihad, E. P. Ebsworth, N. M. Anstey, R. N. Price, and E. Tjitra. 2006. Efficacy of existing antimalarial drugs for uncomplicated malaria in Timika, Papua, Indonesia. Indonesian Med. J. 15:221-258.
22. Snounou, G., L. Pinheiro, A. Goncalves, L. Fonseca, F. Dias, K. N. Brown, and V. E. do Rosario. 1993. The importance of sensitive detection of malaria parasites in the human and insect hosts in epidemiological studies, as shown by the analysis of field samples from Guinea Bissau. Trans. R. Soc. Trop. Med. Hyg. 87:649-653.
23. Tan-ariya, P., and S. Pasuralertsakul. 1994. First report of in vitro susceptibility of Plasmodium malariae Thai isolates to chloroquine. Southeast Asian J. Trop. Med. Public Health 25:784-787.
24. Tanomsing, N., M. Imwong, S. Pukrittayakamee, K. Chotivanich, S. Looareesuwan, M. Mayxay, C. Dolecek, T. T. Hien, V. E. do Rosario, A. P. Arez, P. Michon, G. Snounou, N. J. White, and N. P. Day. 2007. Genetic analysis of the dihydrofolate reductase-thymidylate synthase gene from geographically diverse isolates of Plasmodium malariae. Antimicrob. Agents Chemother. 51:3523-3530.
25. White, N. J. 2002. The assessment of antimalarial drug efficacy. Trends Parasitol. 18:458-464.
26. White, N. J. 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1413-1422.
27. White, N. J. 2009. Malaria, p. 1201-1300. In G. C. Cook and A. I. Zumla (ed.), Manson's tropical diseases, 22nd ed. W. B. Saunders, Edinburgh, United Kingdom.
28. White, N. J., F. Nosten, S. Looareesuwan, W. M. Watkins, K. Marsh, R. W. Snow, G. Kokwaro, J. Ouma, T. T. Hien, M. E. Molyneux, T. E. Taylor, C. I. Newbold, T. K. Ruebush II, M. Danis, B. M. Greenwood, R. M. Anderson, and P. Olliaro. 1999. Averting a malaria disaster. Lancet 353:1965-1967.
29. WHO. 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO, Geneva, Switzerland.
30. WHO. 2000. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans. R. Soc. Trop. Med. Hyg. 94(Suppl. 1): S1-S90.
31. Young, M. D., and D. E. Eyles. 1948. The efficacy of chloroquine, quinacrine, quinine and totaquine in the treatment of Plasmodium malariae infections (quartan malaria). Am. J. Trop. Med. Hyg. 28:23-28.